73 related articles for article (PubMed ID: 30590005)
1. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
Am J Hum Genet; 2024 May; ():. PubMed ID: 38749429
[TBL] [Abstract][Full Text] [Related]
2. A unique case of rectal cancer with coexistence of multiple pathways of carcinogenesis.
Rateria N; Ojha R; Shukla M; Pandey M
World J Surg Oncol; 2023 Sep; 21(1):275. PubMed ID: 37658412
[TBL] [Abstract][Full Text] [Related]
3. Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization.
Valentini V; Alfieri S; Coco C; D'Ugo D; Crucitti A; Pacelli F; Persiani R; Sofo L; Picciocchi A; Doglietto GB; Barbaro B; Vecchio FM; Ricci R; Damiani A; Savino MC; Boldrini L; Cellini F; Meldolesi E; Romano A; Chiloiro G; Gambacorta MA
Radiother Oncol; 2024 May; 194():110190. PubMed ID: 38438019
[No Abstract] [Full Text] [Related]
4. Analysis of MUTYH alternative transcript expression, promoter function, and the effect of human genetic variants.
Köger N; Brieger A; Hinrichsen IM; Zeuzem S; Plotz G
Hum Mutat; 2019 Apr; 40(4):472-482. PubMed ID: 30653782
[TBL] [Abstract][Full Text] [Related]
5. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
[TBL] [Abstract][Full Text] [Related]
6. BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Kwon JS; Tinker AV; Hanley GE; Pansegrau G; Sun S; Carey MS; Schrader I
Gynecol Oncol; 2019 Mar; 152(3):459-464. PubMed ID: 30876489
[TBL] [Abstract][Full Text] [Related]
7. Human RAD52 protein regulates homologous recombination and checkpoint function in BRCA2 deficient cells.
Mahajan S; Raina K; Verma S; Rao BJ
Int J Biochem Cell Biol; 2019 Feb; 107():128-139. PubMed ID: 30590106
[TBL] [Abstract][Full Text] [Related]
8. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Xue Y; Meehan B; Fu Z; Wang XQD; Fiset PO; Rieker R; Levins C; Kong T; Zhu X; Morin G; Skerritt L; Herpel E; Venneti S; Martinez D; Judkins AR; Jung S; Camilleri-Broet S; Gonzalez AV; Guiot MC; Lockwood WW; Spicer JD; Agaimy A; Pastor WA; Dostie J; Rak J; Foulkes WD; Huang S
Nat Commun; 2019 Feb; 10(1):557. PubMed ID: 30718506
[TBL] [Abstract][Full Text] [Related]
9. MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway.
Zhong A; Zheng H; Zhang H; Sun J; Shen J; Deng M; Chen M; Lu R; Guo L
J Cancer; 2019; 10(10):2276-2287. PubMed ID: 31258731
[TBL] [Abstract][Full Text] [Related]
10. WRN helicase is a synthetic lethal target in microsatellite unstable cancers.
Chan EM; Shibue T; McFarland JM; Gaeta B; Ghandi M; Dumont N; Gonzalez A; McPartlan JS; Li T; Zhang Y; Bin Liu J; Lazaro JB; Gu P; Piett CG; Apffel A; Ali SO; Deasy R; Keskula P; Ng RWS; Roberts EA; Reznichenko E; Leung L; Alimova M; Schenone M; Islam M; Maruvka YE; Liu Y; Roper J; Raghavan S; Giannakis M; Tseng YY; Nagel ZD; D'Andrea A; Root DE; Boehm JS; Getz G; Chang S; Golub TR; Tsherniak A; Vazquez F; Bass AJ
Nature; 2019 Apr; 568(7753):551-556. PubMed ID: 30971823
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers.
Salama V; Geng Y; Rigert J; Fuller CD; Shete S; Moreno AC
Clin Transl Radiat Oncol; 2023 Nov; 43():100669. PubMed ID: 37954025
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy.
Chen H; Yin L; Yang J; Ren N; Chen J; Lu Q; Huang Y; Feng Y; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Biol Med; 2023 May; 20(4):297-316. PubMed ID: 37144561
[TBL] [Abstract][Full Text] [Related]
13. Dietary methyl donor nutrients, DNA mismatch repair polymorphisms, and risk of colorectal cancer based on microsatellite instability status.
Kim J; Lee J; Oh JH; Sohn DK; Shin A; Kim J; Chang HJ
Eur J Nutr; 2022 Sep; 61(6):3051-3066. PubMed ID: 35353199
[TBL] [Abstract][Full Text] [Related]
14. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract][Full Text] [Related]
15. Potential Functional Variants in DNA Repair Genes Are Associated with Efficacy and Toxicity of Radiotherapy in Patients with Non-Small-Cell Lung Cancer.
Yang Z; Liu Z
J Oncol; 2020; 2020():3132786. PubMed ID: 32684929
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.
Li X; Wu Y; Suo P; Liu G; Li L; Zhang X; Chen S; Xu M; Song L
Medicine (Baltimore); 2020 Jan; 99(5):e19076. PubMed ID: 32000458
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammation score in locally advanced rectal cancer patients following total mesorectal excision.
Feng Y; Liu L; Zhu Y
Onco Targets Ther; 2019; 12():6617-6622. PubMed ID: 31695404
[TBL] [Abstract][Full Text] [Related]
18. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
